nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—ABCC2—bile—alcohol dependence	0.0291	0.264	CbGeAlD
Olmesartan—AGTR1—Allograft Rejection—PECR—alcohol dependence	0.0112	0.0705	CbGpPWpGaD
Olmesartan—SLCO1B3—Transport of organic anions—AVP—alcohol dependence	0.0092	0.0579	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—OPRK1—alcohol dependence	0.00729	0.0459	CbGpPWpGaD
Olmesartan—AGTR1—forebrain—alcohol dependence	0.00627	0.0569	CbGeAlD
Olmesartan—SLCO1B1—Transport of organic anions—AVP—alcohol dependence	0.00618	0.0389	CbGpPWpGaD
Olmesartan—SLCO1B3—endocrine gland—alcohol dependence	0.00599	0.0544	CbGeAlD
Olmesartan—AGTR1—adrenal cortex—alcohol dependence	0.00581	0.0527	CbGeAlD
Olmesartan—SLCO1B3—liver—alcohol dependence	0.0054	0.049	CbGeAlD
Olmesartan—AGTR1—cardiovascular system—alcohol dependence	0.0053	0.0481	CbGeAlD
Olmesartan—AGTR1—Peptide GPCRs—OPRD1—alcohol dependence	0.0049	0.0308	CbGpPWpGaD
Olmesartan—SLCO1B1—digestive system—alcohol dependence	0.00419	0.0381	CbGeAlD
Olmesartan—AGTR1—blood—alcohol dependence	0.00419	0.038	CbGeAlD
Olmesartan—SLCO1B1—blood—alcohol dependence	0.004	0.0363	CbGeAlD
Olmesartan—AGTR1—Peptide GPCRs—OPRM1—alcohol dependence	0.00377	0.0237	CbGpPWpGaD
Olmesartan—AGTR1—endocrine gland—alcohol dependence	0.00363	0.033	CbGeAlD
Olmesartan—AGTR1—testis—alcohol dependence	0.00347	0.0315	CbGeAlD
Olmesartan—SLCO1B1—endocrine gland—alcohol dependence	0.00347	0.0314	CbGeAlD
Olmesartan—AGTR1—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00343	0.0216	CbGpPWpGaD
Olmesartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00341	0.0215	CbGpPWpGaD
Olmesartan—AGTR1—nervous system—alcohol dependence	0.0034	0.0309	CbGeAlD
Olmesartan—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.0034	0.00465	CcSEcCtD
Olmesartan—Gout—Citalopram—alcohol dependence	0.00334	0.00457	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00333	0.00455	CcSEcCtD
Olmesartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00331	0.0208	CbGpPWpGaD
Olmesartan—Blood bilirubin increased—Citalopram—alcohol dependence	0.00329	0.00451	CcSEcCtD
Olmesartan—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00329	0.00451	CcSEcCtD
Olmesartan—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00329	0.00451	CcSEcCtD
Olmesartan—AGTR1—liver—alcohol dependence	0.00328	0.0297	CbGeAlD
Olmesartan—AGTR1—central nervous system—alcohol dependence	0.00327	0.0297	CbGeAlD
Olmesartan—Influenza—Acamprosate—alcohol dependence	0.00326	0.00446	CcSEcCtD
Olmesartan—Bone pain—Citalopram—alcohol dependence	0.00325	0.00445	CcSEcCtD
Olmesartan—Fatigue—Disulfiram—alcohol dependence	0.00325	0.00444	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—ALDH3A1—alcohol dependence	0.00324	0.0204	CbGpPWpGaD
Olmesartan—Eosinophilia—Acamprosate—alcohol dependence	0.00323	0.00442	CcSEcCtD
Olmesartan—Pain—Disulfiram—alcohol dependence	0.00322	0.0044	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00321	0.0044	CcSEcCtD
Olmesartan—Pancreatitis—Acamprosate—alcohol dependence	0.0032	0.00437	CcSEcCtD
Olmesartan—Nasopharyngitis—Naltrexone—alcohol dependence	0.00319	0.00437	CcSEcCtD
Olmesartan—ABCC2—digestive system—alcohol dependence	0.00318	0.0289	CbGeAlD
Olmesartan—Angina pectoris—Acamprosate—alcohol dependence	0.00318	0.00435	CcSEcCtD
Olmesartan—Blood uric acid increased—Citalopram—alcohol dependence	0.00317	0.00434	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00315	0.00431	CcSEcCtD
Olmesartan—Bronchitis—Acamprosate—alcohol dependence	0.00314	0.00429	CcSEcCtD
Olmesartan—SLCO1B1—liver—alcohol dependence	0.00312	0.0284	CbGeAlD
Olmesartan—Influenza—Naltrexone—alcohol dependence	0.00309	0.00422	CcSEcCtD
Olmesartan—ABCC2—blood—alcohol dependence	0.00303	0.0275	CbGeAlD
Olmesartan—Influenza like illness—Citalopram—alcohol dependence	0.00303	0.00414	CcSEcCtD
Olmesartan—Angina pectoris—Naltrexone—alcohol dependence	0.00301	0.00411	CcSEcCtD
Olmesartan—Erectile dysfunction—Acamprosate—alcohol dependence	0.003	0.00411	CcSEcCtD
Olmesartan—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00298	0.00407	CcSEcCtD
Olmesartan—Bronchitis—Naltrexone—alcohol dependence	0.00297	0.00406	CcSEcCtD
Olmesartan—Hyperglycaemia—Acamprosate—alcohol dependence	0.00294	0.00402	CcSEcCtD
Olmesartan—Aplastic anaemia—Citalopram—alcohol dependence	0.00293	0.004	CcSEcCtD
Olmesartan—Pneumonia—Acamprosate—alcohol dependence	0.00292	0.004	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00287	0.00392	CcSEcCtD
Olmesartan—Urinary tract infection—Acamprosate—alcohol dependence	0.00283	0.00387	CcSEcCtD
Olmesartan—Lightheadedness—Citalopram—alcohol dependence	0.00279	0.00381	CcSEcCtD
Olmesartan—Haematuria—Acamprosate—alcohol dependence	0.00277	0.00379	CcSEcCtD
Olmesartan—Pneumonia—Naltrexone—alcohol dependence	0.00277	0.00379	CcSEcCtD
Olmesartan—Infestation—Naltrexone—alcohol dependence	0.00275	0.00376	CcSEcCtD
Olmesartan—Infestation NOS—Naltrexone—alcohol dependence	0.00275	0.00376	CcSEcCtD
Olmesartan—Asthenia—Disulfiram—alcohol dependence	0.0027	0.0037	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00268	0.0169	CbGpPWpGaD
Olmesartan—Urinary tract infection—Naltrexone—alcohol dependence	0.00267	0.00366	CcSEcCtD
Olmesartan—ABCC2—endocrine gland—alcohol dependence	0.00263	0.0238	CbGeAlD
Olmesartan—Rhinitis—Acamprosate—alcohol dependence	0.00262	0.00358	CcSEcCtD
Olmesartan—Sleep disorder—Citalopram—alcohol dependence	0.00261	0.00357	CcSEcCtD
Olmesartan—Diabetes mellitus—Citalopram—alcohol dependence	0.0026	0.00356	CcSEcCtD
Olmesartan—AGTR1—brain—alcohol dependence	0.0026	0.0236	CbGeAlD
Olmesartan—Pharyngitis—Acamprosate—alcohol dependence	0.00259	0.00354	CcSEcCtD
Olmesartan—Sinusitis—Naltrexone—alcohol dependence	0.00258	0.00353	CcSEcCtD
Olmesartan—Oedema peripheral—Acamprosate—alcohol dependence	0.00257	0.00352	CcSEcCtD
Olmesartan—Gastroenteritis—Citalopram—alcohol dependence	0.00255	0.00349	CcSEcCtD
Olmesartan—Eczema—Citalopram—alcohol dependence	0.00252	0.00344	CcSEcCtD
Olmesartan—ABCC2—testis—alcohol dependence	0.00251	0.0227	CbGeAlD
Olmesartan—Haemolytic anaemia—Citalopram—alcohol dependence	0.00251	0.00343	CcSEcCtD
Olmesartan—Dizziness—Disulfiram—alcohol dependence	0.00249	0.00341	CcSEcCtD
Olmesartan—Injury—Citalopram—alcohol dependence	0.00246	0.00337	CcSEcCtD
Olmesartan—Pharyngitis—Naltrexone—alcohol dependence	0.00245	0.00335	CcSEcCtD
Olmesartan—Renal failure acute—Citalopram—alcohol dependence	0.00245	0.00335	CcSEcCtD
Olmesartan—Connective tissue disorder—Naltrexone—alcohol dependence	0.00243	0.00332	CcSEcCtD
Olmesartan—Rash—Disulfiram—alcohol dependence	0.00237	0.00325	CcSEcCtD
Olmesartan—ABCC2—liver—alcohol dependence	0.00237	0.0215	CbGeAlD
Olmesartan—Headache—Disulfiram—alcohol dependence	0.00236	0.00323	CcSEcCtD
Olmesartan—Arthritis—Citalopram—alcohol dependence	0.00233	0.00318	CcSEcCtD
Olmesartan—Lethargy—Citalopram—alcohol dependence	0.00231	0.00316	CcSEcCtD
Olmesartan—Alopecia—Acamprosate—alcohol dependence	0.00231	0.00316	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.0023	0.0145	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.0023	0.0145	CbGpPWpGaD
Olmesartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00229	0.0144	CbGpPWpGaD
Olmesartan—Mental disorder—Acamprosate—alcohol dependence	0.00229	0.00313	CcSEcCtD
Olmesartan—Malnutrition—Acamprosate—alcohol dependence	0.00227	0.00311	CcSEcCtD
Olmesartan—Hyponatraemia—Citalopram—alcohol dependence	0.00227	0.00311	CcSEcCtD
Olmesartan—Pain in extremity—Citalopram—alcohol dependence	0.00226	0.00309	CcSEcCtD
Olmesartan—Angiopathy—Naltrexone—alcohol dependence	0.00224	0.00307	CcSEcCtD
Olmesartan—Mediastinal disorder—Naltrexone—alcohol dependence	0.00223	0.00304	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00221	0.0139	CbGpPWpGaD
Olmesartan—Back pain—Acamprosate—alcohol dependence	0.0022	0.00301	CcSEcCtD
Olmesartan—Muscle spasms—Acamprosate—alcohol dependence	0.00218	0.00299	CcSEcCtD
Olmesartan—Face oedema—Citalopram—alcohol dependence	0.00218	0.00299	CcSEcCtD
Olmesartan—Alopecia—Naltrexone—alcohol dependence	0.00218	0.00299	CcSEcCtD
Olmesartan—Mental disorder—Naltrexone—alcohol dependence	0.00216	0.00296	CcSEcCtD
Olmesartan—Malnutrition—Naltrexone—alcohol dependence	0.00215	0.00294	CcSEcCtD
Olmesartan—Ill-defined disorder—Acamprosate—alcohol dependence	0.00211	0.00288	CcSEcCtD
Olmesartan—Anaemia—Acamprosate—alcohol dependence	0.0021	0.00287	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—ADH7—alcohol dependence	0.00209	0.0131	CbGpPWpGaD
Olmesartan—Agitation—Acamprosate—alcohol dependence	0.00209	0.00286	CcSEcCtD
Olmesartan—Back pain—Naltrexone—alcohol dependence	0.00208	0.00284	CcSEcCtD
Olmesartan—Angioedema—Acamprosate—alcohol dependence	0.00208	0.00284	CcSEcCtD
Olmesartan—Muscle spasms—Naltrexone—alcohol dependence	0.00207	0.00283	CcSEcCtD
Olmesartan—Orthostatic hypotension—Citalopram—alcohol dependence	0.00207	0.00283	CcSEcCtD
Olmesartan—Hypokalaemia—Citalopram—alcohol dependence	0.00206	0.00282	CcSEcCtD
Olmesartan—Malaise—Acamprosate—alcohol dependence	0.00205	0.0028	CcSEcCtD
Olmesartan—Vertigo—Acamprosate—alcohol dependence	0.00204	0.00279	CcSEcCtD
Olmesartan—Syncope—Acamprosate—alcohol dependence	0.00204	0.00279	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00204	0.00279	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00204	0.00279	CcSEcCtD
Olmesartan—Leukopenia—Acamprosate—alcohol dependence	0.00203	0.00278	CcSEcCtD
Olmesartan—Vision blurred—Naltrexone—alcohol dependence	0.00203	0.00277	CcSEcCtD
Olmesartan—Nasopharyngitis—Citalopram—alcohol dependence	0.00202	0.00277	CcSEcCtD
Olmesartan—Palpitations—Acamprosate—alcohol dependence	0.00201	0.00275	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—GGT2—alcohol dependence	0.002	0.0126	CbGpPWpGaD
Olmesartan—Loss of consciousness—Acamprosate—alcohol dependence	0.002	0.00273	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00199	0.00273	CcSEcCtD
Olmesartan—Ill-defined disorder—Naltrexone—alcohol dependence	0.00199	0.00273	CcSEcCtD
Olmesartan—Cough—Acamprosate—alcohol dependence	0.00198	0.00271	CcSEcCtD
Olmesartan—Agitation—Naltrexone—alcohol dependence	0.00198	0.0027	CcSEcCtD
Olmesartan—Angioedema—Naltrexone—alcohol dependence	0.00196	0.00269	CcSEcCtD
Olmesartan—Influenza—Citalopram—alcohol dependence	0.00195	0.00267	CcSEcCtD
Olmesartan—Malaise—Naltrexone—alcohol dependence	0.00194	0.00265	CcSEcCtD
Olmesartan—Eosinophilia—Citalopram—alcohol dependence	0.00194	0.00265	CcSEcCtD
Olmesartan—Chest pain—Acamprosate—alcohol dependence	0.00193	0.00265	CcSEcCtD
Olmesartan—Arthralgia—Acamprosate—alcohol dependence	0.00193	0.00265	CcSEcCtD
Olmesartan—Myalgia—Acamprosate—alcohol dependence	0.00193	0.00265	CcSEcCtD
Olmesartan—Syncope—Naltrexone—alcohol dependence	0.00193	0.00264	CcSEcCtD
Olmesartan—Anxiety—Acamprosate—alcohol dependence	0.00193	0.00264	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00192	0.00263	CcSEcCtD
Olmesartan—Pancreatitis—Citalopram—alcohol dependence	0.00192	0.00262	CcSEcCtD
Olmesartan—Discomfort—Acamprosate—alcohol dependence	0.00191	0.00261	CcSEcCtD
Olmesartan—Angina pectoris—Citalopram—alcohol dependence	0.0019	0.00261	CcSEcCtD
Olmesartan—Palpitations—Naltrexone—alcohol dependence	0.0019	0.0026	CcSEcCtD
Olmesartan—Loss of consciousness—Naltrexone—alcohol dependence	0.00189	0.00258	CcSEcCtD
Olmesartan—Bronchitis—Citalopram—alcohol dependence	0.00188	0.00257	CcSEcCtD
Olmesartan—Cough—Naltrexone—alcohol dependence	0.00188	0.00257	CcSEcCtD
Olmesartan—Pancytopenia—Citalopram—alcohol dependence	0.00186	0.00254	CcSEcCtD
Olmesartan—Anaphylactic shock—Acamprosate—alcohol dependence	0.00185	0.00254	CcSEcCtD
Olmesartan—Infection—Acamprosate—alcohol dependence	0.00184	0.00252	CcSEcCtD
Olmesartan—Chest pain—Naltrexone—alcohol dependence	0.00183	0.0025	CcSEcCtD
Olmesartan—Myalgia—Naltrexone—alcohol dependence	0.00183	0.0025	CcSEcCtD
Olmesartan—Arthralgia—Naltrexone—alcohol dependence	0.00183	0.0025	CcSEcCtD
Olmesartan—Shock—Acamprosate—alcohol dependence	0.00182	0.0025	CcSEcCtD
Olmesartan—Anxiety—Naltrexone—alcohol dependence	0.00182	0.0025	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00182	0.00249	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00182	0.00249	CcSEcCtD
Olmesartan—Thrombocytopenia—Acamprosate—alcohol dependence	0.00182	0.00248	CcSEcCtD
Olmesartan—Tachycardia—Acamprosate—alcohol dependence	0.00181	0.00248	CcSEcCtD
Olmesartan—Discomfort—Naltrexone—alcohol dependence	0.00181	0.00247	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.0018	0.0114	CbGpPWpGaD
Olmesartan—Skin disorder—Acamprosate—alcohol dependence	0.0018	0.00246	CcSEcCtD
Olmesartan—Erectile dysfunction—Citalopram—alcohol dependence	0.0018	0.00246	CcSEcCtD
Olmesartan—Hyperhidrosis—Acamprosate—alcohol dependence	0.00179	0.00245	CcSEcCtD
Olmesartan—Photosensitivity reaction—Citalopram—alcohol dependence	0.00178	0.00244	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00177	0.0112	CbGpPWpGaD
Olmesartan—Anorexia—Acamprosate—alcohol dependence	0.00177	0.00242	CcSEcCtD
Olmesartan—Hyperglycaemia—Citalopram—alcohol dependence	0.00176	0.00241	CcSEcCtD
Olmesartan—Oedema—Naltrexone—alcohol dependence	0.00175	0.0024	CcSEcCtD
Olmesartan—Anaphylactic shock—Naltrexone—alcohol dependence	0.00175	0.0024	CcSEcCtD
Olmesartan—Pneumonia—Citalopram—alcohol dependence	0.00175	0.0024	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—OPRK1—alcohol dependence	0.00175	0.011	CbGpPWpGaD
Olmesartan—Infection—Naltrexone—alcohol dependence	0.00174	0.00238	CcSEcCtD
Olmesartan—Infestation—Citalopram—alcohol dependence	0.00174	0.00238	CcSEcCtD
Olmesartan—Infestation NOS—Citalopram—alcohol dependence	0.00174	0.00238	CcSEcCtD
Olmesartan—Hypotension—Acamprosate—alcohol dependence	0.00173	0.00237	CcSEcCtD
Olmesartan—Shock—Naltrexone—alcohol dependence	0.00173	0.00236	CcSEcCtD
Olmesartan—Nervous system disorder—Naltrexone—alcohol dependence	0.00172	0.00235	CcSEcCtD
Olmesartan—Tachycardia—Naltrexone—alcohol dependence	0.00171	0.00234	CcSEcCtD
Olmesartan—Skin disorder—Naltrexone—alcohol dependence	0.0017	0.00233	CcSEcCtD
Olmesartan—Jaundice—Citalopram—alcohol dependence	0.0017	0.00232	CcSEcCtD
Olmesartan—Hyperhidrosis—Naltrexone—alcohol dependence	0.0017	0.00232	CcSEcCtD
Olmesartan—Urinary tract infection—Citalopram—alcohol dependence	0.00169	0.00232	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00169	0.00231	CcSEcCtD
Olmesartan—Insomnia—Acamprosate—alcohol dependence	0.00168	0.00229	CcSEcCtD
Olmesartan—Anorexia—Naltrexone—alcohol dependence	0.00167	0.00229	CcSEcCtD
Olmesartan—Haematuria—Citalopram—alcohol dependence	0.00166	0.00227	CcSEcCtD
Olmesartan—Sinusitis—Citalopram—alcohol dependence	0.00164	0.00224	CcSEcCtD
Olmesartan—Dyspepsia—Acamprosate—alcohol dependence	0.00163	0.00223	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00163	0.0103	CbGpPWpGaD
Olmesartan—Agranulocytosis—Citalopram—alcohol dependence	0.00163	0.00223	CcSEcCtD
Olmesartan—Decreased appetite—Acamprosate—alcohol dependence	0.00161	0.00221	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.0016	0.00219	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.0016	0.00219	CcSEcCtD
Olmesartan—Insomnia—Naltrexone—alcohol dependence	0.00159	0.00217	CcSEcCtD
Olmesartan—Pain—Acamprosate—alcohol dependence	0.00159	0.00217	CcSEcCtD
Olmesartan—Constipation—Acamprosate—alcohol dependence	0.00159	0.00217	CcSEcCtD
Olmesartan—Rhinitis—Citalopram—alcohol dependence	0.00157	0.00215	CcSEcCtD
Olmesartan—Pharyngitis—Citalopram—alcohol dependence	0.00155	0.00212	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00155	0.00973	CbGpPWpGaD
Olmesartan—Urinary tract disorder—Citalopram—alcohol dependence	0.00155	0.00211	CcSEcCtD
Olmesartan—Oedema peripheral—Citalopram—alcohol dependence	0.00154	0.00211	CcSEcCtD
Olmesartan—Connective tissue disorder—Citalopram—alcohol dependence	0.00154	0.0021	CcSEcCtD
Olmesartan—Urethral disorder—Citalopram—alcohol dependence	0.00153	0.0021	CcSEcCtD
Olmesartan—Feeling abnormal—Acamprosate—alcohol dependence	0.00153	0.00209	CcSEcCtD
Olmesartan—Decreased appetite—Naltrexone—alcohol dependence	0.00153	0.00209	CcSEcCtD
Olmesartan—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00152	0.00207	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00151	0.00207	CcSEcCtD
Olmesartan—Fatigue—Naltrexone—alcohol dependence	0.00151	0.00207	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00151	0.00951	CbGpPWpGaD
Olmesartan—Constipation—Naltrexone—alcohol dependence	0.0015	0.00205	CcSEcCtD
Olmesartan—Pain—Naltrexone—alcohol dependence	0.0015	0.00205	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00148	0.00932	CbGpPWpGaD
Olmesartan—Urticaria—Acamprosate—alcohol dependence	0.00147	0.00202	CcSEcCtD
Olmesartan—Abdominal pain—Acamprosate—alcohol dependence	0.00147	0.00201	CcSEcCtD
Olmesartan—Body temperature increased—Acamprosate—alcohol dependence	0.00147	0.00201	CcSEcCtD
Olmesartan—Feeling abnormal—Naltrexone—alcohol dependence	0.00145	0.00198	CcSEcCtD
Olmesartan—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00143	0.00196	CcSEcCtD
Olmesartan—Angiopathy—Citalopram—alcohol dependence	0.00142	0.00194	CcSEcCtD
Olmesartan—Mediastinal disorder—Citalopram—alcohol dependence	0.00141	0.00193	CcSEcCtD
Olmesartan—Arrhythmia—Citalopram—alcohol dependence	0.0014	0.00191	CcSEcCtD
Olmesartan—Urticaria—Naltrexone—alcohol dependence	0.00139	0.00191	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00139	0.00873	CbGpPWpGaD
Olmesartan—Abdominal pain—Naltrexone—alcohol dependence	0.00139	0.0019	CcSEcCtD
Olmesartan—Body temperature increased—Naltrexone—alcohol dependence	0.00139	0.0019	CcSEcCtD
Olmesartan—Alopecia—Citalopram—alcohol dependence	0.00138	0.00189	CcSEcCtD
Olmesartan—Mental disorder—Citalopram—alcohol dependence	0.00137	0.00188	CcSEcCtD
Olmesartan—Malnutrition—Citalopram—alcohol dependence	0.00136	0.00186	CcSEcCtD
Olmesartan—Asthenia—Acamprosate—alcohol dependence	0.00133	0.00182	CcSEcCtD
Olmesartan—Back pain—Citalopram—alcohol dependence	0.00132	0.0018	CcSEcCtD
Olmesartan—Pruritus—Acamprosate—alcohol dependence	0.00131	0.00179	CcSEcCtD
Olmesartan—Muscle spasms—Citalopram—alcohol dependence	0.00131	0.00179	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.0013	0.00815	CbGpPWpGaD
Olmesartan—Vision blurred—Citalopram—alcohol dependence	0.00128	0.00176	CcSEcCtD
Olmesartan—Diarrhoea—Acamprosate—alcohol dependence	0.00127	0.00174	CcSEcCtD
Olmesartan—Ill-defined disorder—Citalopram—alcohol dependence	0.00126	0.00173	CcSEcCtD
Olmesartan—Anaemia—Citalopram—alcohol dependence	0.00126	0.00172	CcSEcCtD
Olmesartan—Asthenia—Naltrexone—alcohol dependence	0.00126	0.00172	CcSEcCtD
Olmesartan—Agitation—Citalopram—alcohol dependence	0.00125	0.00171	CcSEcCtD
Olmesartan—Angioedema—Citalopram—alcohol dependence	0.00124	0.0017	CcSEcCtD
Olmesartan—Pruritus—Naltrexone—alcohol dependence	0.00124	0.0017	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00123	0.00775	CbGpPWpGaD
Olmesartan—Malaise—Citalopram—alcohol dependence	0.00123	0.00168	CcSEcCtD
Olmesartan—Dizziness—Acamprosate—alcohol dependence	0.00123	0.00168	CcSEcCtD
Olmesartan—Vertigo—Citalopram—alcohol dependence	0.00122	0.00167	CcSEcCtD
Olmesartan—Syncope—Citalopram—alcohol dependence	0.00122	0.00167	CcSEcCtD
Olmesartan—Leukopenia—Citalopram—alcohol dependence	0.00122	0.00167	CcSEcCtD
Olmesartan—Palpitations—Citalopram—alcohol dependence	0.0012	0.00165	CcSEcCtD
Olmesartan—Diarrhoea—Naltrexone—alcohol dependence	0.0012	0.00164	CcSEcCtD
Olmesartan—Loss of consciousness—Citalopram—alcohol dependence	0.0012	0.00164	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00119	0.00748	CbGpPWpGaD
Olmesartan—Cough—Citalopram—alcohol dependence	0.00119	0.00163	CcSEcCtD
Olmesartan—Vomiting—Acamprosate—alcohol dependence	0.00118	0.00161	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—OPRD1—alcohol dependence	0.00118	0.00741	CbGpPWpGaD
Olmesartan—Rash—Acamprosate—alcohol dependence	0.00117	0.0016	CcSEcCtD
Olmesartan—Dermatitis—Acamprosate—alcohol dependence	0.00117	0.0016	CcSEcCtD
Olmesartan—Headache—Acamprosate—alcohol dependence	0.00116	0.00159	CcSEcCtD
Olmesartan—Dizziness—Naltrexone—alcohol dependence	0.00116	0.00159	CcSEcCtD
Olmesartan—Chest pain—Citalopram—alcohol dependence	0.00116	0.00159	CcSEcCtD
Olmesartan—Arthralgia—Citalopram—alcohol dependence	0.00116	0.00159	CcSEcCtD
Olmesartan—Myalgia—Citalopram—alcohol dependence	0.00116	0.00159	CcSEcCtD
Olmesartan—Anxiety—Citalopram—alcohol dependence	0.00116	0.00158	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00115	0.00158	CcSEcCtD
Olmesartan—Discomfort—Citalopram—alcohol dependence	0.00115	0.00157	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—PDYN—alcohol dependence	0.00113	0.0071	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—SLC6A4—alcohol dependence	0.00113	0.0071	CbGpPWpGaD
Olmesartan—Vomiting—Naltrexone—alcohol dependence	0.00112	0.00153	CcSEcCtD
Olmesartan—Anaphylactic shock—Citalopram—alcohol dependence	0.00111	0.00152	CcSEcCtD
Olmesartan—Oedema—Citalopram—alcohol dependence	0.00111	0.00152	CcSEcCtD
Olmesartan—Rash—Naltrexone—alcohol dependence	0.00111	0.00151	CcSEcCtD
Olmesartan—Dermatitis—Naltrexone—alcohol dependence	0.00111	0.00151	CcSEcCtD
Olmesartan—Infection—Citalopram—alcohol dependence	0.0011	0.00151	CcSEcCtD
Olmesartan—Nausea—Acamprosate—alcohol dependence	0.0011	0.00151	CcSEcCtD
Olmesartan—Headache—Naltrexone—alcohol dependence	0.0011	0.0015	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00109	0.00689	CbGpPWpGaD
Olmesartan—Shock—Citalopram—alcohol dependence	0.00109	0.0015	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—AVP—alcohol dependence	0.00109	0.00688	CbGpPWpGaD
Olmesartan—Nervous system disorder—Citalopram—alcohol dependence	0.00109	0.00149	CcSEcCtD
Olmesartan—Thrombocytopenia—Citalopram—alcohol dependence	0.00109	0.00149	CcSEcCtD
Olmesartan—Tachycardia—Citalopram—alcohol dependence	0.00108	0.00148	CcSEcCtD
Olmesartan—Skin disorder—Citalopram—alcohol dependence	0.00108	0.00148	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—AVP—alcohol dependence	0.00108	0.00679	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00108	0.00678	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Citalopram—alcohol dependence	0.00107	0.00147	CcSEcCtD
Olmesartan—Anorexia—Citalopram—alcohol dependence	0.00106	0.00145	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00106	0.00664	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CRHR1—alcohol dependence	0.00105	0.0066	CbGpPWpGaD
Olmesartan—Nausea—Naltrexone—alcohol dependence	0.00104	0.00143	CcSEcCtD
Olmesartan—Hypotension—Citalopram—alcohol dependence	0.00104	0.00142	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.00103	0.00647	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00101	0.00139	CcSEcCtD
Olmesartan—Insomnia—Citalopram—alcohol dependence	0.00101	0.00138	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—SLC6A3—alcohol dependence	0.00101	0.00633	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.001	0.00631	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.001	0.00631	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—OPRK1—alcohol dependence	0.000989	0.00623	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CHRM2—alcohol dependence	0.000986	0.00621	CbGpPWpGaD
Olmesartan—Dyspepsia—Citalopram—alcohol dependence	0.000978	0.00134	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000977	0.00615	CbGpPWpGaD
Olmesartan—Decreased appetite—Citalopram—alcohol dependence	0.000966	0.00132	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00096	0.00131	CcSEcCtD
Olmesartan—Fatigue—Citalopram—alcohol dependence	0.000958	0.00131	CcSEcCtD
Olmesartan—Constipation—Citalopram—alcohol dependence	0.000951	0.0013	CcSEcCtD
Olmesartan—Pain—Citalopram—alcohol dependence	0.000951	0.0013	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—GGT1—alcohol dependence	0.000947	0.00596	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000935	0.00588	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000923	0.00581	CbGpPWpGaD
Olmesartan—Feeling abnormal—Citalopram—alcohol dependence	0.000916	0.00125	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—HTR2A—alcohol dependence	0.000909	0.00572	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Citalopram—alcohol dependence	0.000909	0.00124	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—OPRM1—alcohol dependence	0.000905	0.0057	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—OPRK1—alcohol dependence	0.000899	0.00565	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000885	0.00557	CbGpPWpGaD
Olmesartan—Urticaria—Citalopram—alcohol dependence	0.000883	0.00121	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000881	0.00555	CbGpPWpGaD
Olmesartan—Body temperature increased—Citalopram—alcohol dependence	0.000879	0.0012	CcSEcCtD
Olmesartan—Abdominal pain—Citalopram—alcohol dependence	0.000879	0.0012	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00086	0.00541	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00086	0.00541	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—NPY—alcohol dependence	0.000833	0.00524	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000813	0.00512	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR1B—alcohol dependence	0.000804	0.00506	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CRH—alcohol dependence	0.000804	0.00506	CbGpPWpGaD
Olmesartan—Asthenia—Citalopram—alcohol dependence	0.000798	0.00109	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000795	0.005	CbGpPWpGaD
Olmesartan—Pruritus—Citalopram—alcohol dependence	0.000786	0.00108	CcSEcCtD
Olmesartan—Diarrhoea—Citalopram—alcohol dependence	0.000761	0.00104	CcSEcCtD
Olmesartan—Dizziness—Citalopram—alcohol dependence	0.000735	0.00101	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000732	0.00461	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADH6—alcohol dependence	0.000731	0.0046	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000724	0.00455	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000717	0.00451	CbGpPWpGaD
Olmesartan—Vomiting—Citalopram—alcohol dependence	0.000707	0.000967	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000703	0.00442	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—DRD4—alcohol dependence	0.000703	0.00442	CbGpPWpGaD
Olmesartan—Rash—Citalopram—alcohol dependence	0.000701	0.000959	CcSEcCtD
Olmesartan—Dermatitis—Citalopram—alcohol dependence	0.0007	0.000958	CcSEcCtD
Olmesartan—Headache—Citalopram—alcohol dependence	0.000696	0.000953	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CNR1—alcohol dependence	0.000671	0.00422	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000669	0.00421	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—OPRD1—alcohol dependence	0.000665	0.00419	CbGpPWpGaD
Olmesartan—Nausea—Citalopram—alcohol dependence	0.00066	0.000903	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—HTR7—alcohol dependence	0.000655	0.00412	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—DRD2—alcohol dependence	0.000655	0.00412	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PDYN—alcohol dependence	0.000638	0.00401	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000628	0.00395	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADH1A—alcohol dependence	0.000606	0.00381	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—OPRD1—alcohol dependence	0.000604	0.0038	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000602	0.00379	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000595	0.00374	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CRHR1—alcohol dependence	0.000593	0.00373	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PDYN—alcohol dependence	0.000579	0.00364	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000569	0.00358	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CHRM2—alcohol dependence	0.000557	0.00351	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AVP—alcohol dependence	0.000551	0.00347	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CRHR1—alcohol dependence	0.000538	0.00339	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000534	0.00336	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OPRK1—alcohol dependence	0.000531	0.00334	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADH4—alcohol dependence	0.000515	0.00324	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—OPRM1—alcohol dependence	0.000512	0.00322	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CHRM2—alcohol dependence	0.000506	0.00319	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000492	0.0031	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADH6—alcohol dependence	0.000491	0.00309	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000481	0.00303	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPY—alcohol dependence	0.000471	0.00296	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—OPRM1—alcohol dependence	0.000465	0.00292	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR2A—alcohol dependence	0.000458	0.00289	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CRH—alcohol dependence	0.000454	0.00286	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR1B—alcohol dependence	0.000454	0.00286	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00045	0.00283	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000446	0.00281	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADH7—alcohol dependence	0.000438	0.00276	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPY—alcohol dependence	0.000428	0.00269	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GGT2—alcohol dependence	0.00042	0.00264	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CRH—alcohol dependence	0.000413	0.0026	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR1B—alcohol dependence	0.000413	0.0026	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADH1A—alcohol dependence	0.000407	0.00256	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—DRD4—alcohol dependence	0.000397	0.0025	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADH1B—alcohol dependence	0.000384	0.00242	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CNR1—alcohol dependence	0.000379	0.00239	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000372	0.00234	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—DRD2—alcohol dependence	0.00037	0.00233	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR7—alcohol dependence	0.00037	0.00233	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—POMC—alcohol dependence	0.000366	0.0023	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—DRD4—alcohol dependence	0.000361	0.00227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OPRD1—alcohol dependence	0.000357	0.00225	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADH4—alcohol dependence	0.000346	0.00218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CNR1—alcohol dependence	0.000344	0.00217	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDYN—alcohol dependence	0.000342	0.00215	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—DRD2—alcohol dependence	0.000336	0.00211	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR7—alcohol dependence	0.000336	0.00211	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000322	0.00203	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MAOB—alcohol dependence	0.000318	0.002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—WASF2—alcohol dependence	0.000318	0.002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRHR1—alcohol dependence	0.000318	0.002	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AVP—alcohol dependence	0.000311	0.00196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—WASF1—alcohol dependence	0.000305	0.00192	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000302	0.0019	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.0003	0.00189	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CHRM2—alcohol dependence	0.000299	0.00188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADH7—alcohol dependence	0.000294	0.00185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AVP—alcohol dependence	0.000283	0.00178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GGT2—alcohol dependence	0.000282	0.00178	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OPRM1—alcohol dependence	0.000274	0.00173	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALDH2—alcohol dependence	0.000271	0.0017	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000266	0.00168	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.00026	0.00164	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000259	0.00163	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADH1B—alcohol dependence	0.000258	0.00162	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPY—alcohol dependence	0.000253	0.00159	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.00025	0.00157	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRH—alcohol dependence	0.000244	0.00153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR1B—alcohol dependence	0.000244	0.00153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—alcohol dependence	0.000235	0.00148	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GOT2—alcohol dependence	0.00023	0.00145	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2E1—alcohol dependence	0.000216	0.00136	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MAOB—alcohol dependence	0.000214	0.00135	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DRD4—alcohol dependence	0.000213	0.00134	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—alcohol dependence	0.000207	0.0013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CNR1—alcohol dependence	0.000203	0.00128	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GGT1—alcohol dependence	0.000199	0.00125	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GOT1—alcohol dependence	0.000199	0.00125	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR7—alcohol dependence	0.000198	0.00125	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DRD2—alcohol dependence	0.000198	0.00125	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—alcohol dependence	0.000188	0.00118	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDH2—alcohol dependence	0.000182	0.00114	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MAOA—alcohol dependence	0.000178	0.00112	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000175	0.0011	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000173	0.00109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AVP—alcohol dependence	0.000167	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GOT2—alcohol dependence	0.000155	0.000973	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2E1—alcohol dependence	0.000145	0.000914	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—alcohol dependence	0.000139	0.000875	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GGT1—alcohol dependence	0.000133	0.00084	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GOT1—alcohol dependence	0.000133	0.00084	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MAOA—alcohol dependence	0.00012	0.000752	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000116	0.00073	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—alcohol dependence	0.000116	0.000729	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—alcohol dependence	0.000111	0.000699	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—alcohol dependence	7.78e-05	0.00049	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—EP300—alcohol dependence	7.68e-05	0.000484	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EP300—alcohol dependence	7.36e-05	0.000463	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—EP300—alcohol dependence	5.16e-05	0.000325	CbGpPWpGaD
